Main finding: Ahmed tube was associated with more adjunctive medication to achieve equal success compared to Baerveldt tube and resulted in a greater relative risk of reoperation
Purpose: To compare outcomes and complications of the Ahmed FP7 Glaucoma Valve and the Baerveldt Glaucoma Implant (BGI) 101-350 for the treatment of refractory glaucoma.
Study type: Randomized controlled trial
Condition: Uncontrolled glaucoma
Participants: 18yo-85yo uncontrolled glaucoma refractory to maximal medical therapy, IOP ≥18, may have previously failed trab
n=276
Intervention:
Group 1: Ahmed FP7 Glaucoma Valve
Group 2: Baerveldt Glaucoma Implant (BGI) 101-350
The mean IOP and number of glaucoma medications was significantly higher in the Ahmed group (14.3 mmHg; 2.0) than Baerveldt group (13.1mmHg; 1.5)
Share This Article :
Please provide feedback on content published. Thank you.
Source Archive